pidilizumab

BIOLOGICAL2 trials

Sponsors

Ohio State University Comprehensive Cancer Center, Northwestern University

Conditions

Multiple MyelomaStage III Diffuse Large B-Cell LymphomaStage IV Diffuse Large B-Cell Lymphoma

Phase 1

Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

TerminatedNCT02077959

Ohio State University Comprehensive Cancer CenterMultiple Myeloma

Start: 2014-03-03End: 2019-05-24Updated: 2023-01-27

Phase 2

Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission

TerminatedNCT02530125

Northwestern UniversityStage III Diffuse Large B-Cell Lymphoma, Stage IV Diffuse Large B-Cell Lymphoma

Start: 2015-09-30End: 2017-01-31Updated: 2018-03-19